celecoxib
- Product NDC
- 55700-613
- 11-digit product format
- 557000613
- Labeler code
- 55700
- Product ID
- 55700-613_52d20bdb-15ee-4058-81cb-be3f0f1ddfc3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Quality Care Products LLC
- Application
- ANDA204590
- Marketing category
- ANDA
- Marketing start
- 2018-05-04
- Marketing end
- 2026-12-31
- Substance
- CELECOXIB
- Active strength
- 100 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- celecoxib
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CELECOXIB | 100 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JCX84Q7J1L |
| Rxcui | 205322 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55700-613-30 | celecoxib | 30 in 1 BOTTLE | CAPSULE | 30 | | 7 |
| 55700-613-60 | celecoxib | 60 in 1 BOTTLE | CAPSULE | 60 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55700-613 | CELECOXIB CAPSULE [QUALITY CARE PRODUCTS LLC] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250101_f0df546e-17c9-4e85-839d-336612d7b9e5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-613-30 | 55700061330 | 30 CAPSULE in 1 BOTTLE (55700-613-30) | 30 capsule | 2018-05-04 | 2026-12-31 | No | No | Current |
| 55700-613-60 | 55700061360 | 60 CAPSULE in 1 BOTTLE (55700-613-60) | 60 capsule | 2018-05-04 | 2026-12-31 | No | No | Current |